Carolynn E. Ohlson
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
-
- interferon and immune responses
- Immune Cell Function and Interaction
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Epigenetics and DNA Methylation 1
- Histone Deacetylase Inhibitors Research 1
- Oncology 3
- Co-authors
- Jean J. Zhao (5 shared papers)Thomas M. Roberts (4 shared papers)Roderick T. Bronson (2 shared papers)Hailing Cheng (4 shared papers)Panagiotis A. Konstantinopoulos (1 shared paper)Qiwei Wang (1 shared paper)Elizabeth H. Stover (1 shared paper)Joyce F. Liu (1 shared paper)
- Journals
- Cell Reports (2 papers)Proceedings of the National Academy of Sciences (1 paper)Oncogene (1 paper)Cancer Research (1 paper)Digital WPI (1 paper)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Carolynn E. Ohlson
6 papers receiving 658 citations
Carolynn E. Ohlson's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 336
- Immunology 196
- Reproductive Medicine 54
- Molecular Biology 334
- Cancer Research 66
Countries citing papers authored by Carolynn E. Ohlson
This map shows the geographic impact of Carolynn E. Ohlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolynn E. Ohlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolynn E. Ohlson more than expected).
Fields of papers citing papers by Carolynn E. Ohlson
This network shows the impact of papers produced by Carolynn E. Ohlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolynn E. Ohlson. The network helps show where Carolynn E. Ohlson may publish in the future.
Co-authors
The 25 scholars most cited alongside Carolynn E. Ohlson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer Hit paper breakdown → | 2018 | 411 |
| 2 | 2016 | 90 | |
| 3 | 2017 | 85 | |
| 4 | 2013 | 46 | |
| 5 | 2015 | 33 | |
| 6 | Breast Cancer in Thailand: Developing Effective and Accessible Media on Integrative Therapies for Breast Cancer Patients | 2011 | 1 |
About Carolynn E. Ohlson
Carolynn E. Ohlson is a scholar working on Molecular Biology, Oncology, Genetics, Infectious Diseases and Cell Biology, having authored 6 papers that have together received 666 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Viral Infections and Outbreaks Research (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Epigenetics and DNA Methylation (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Tuberous Sclerosis Complex Research (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Viral Infections and Vectors (1 paper). The work is most often cited by research in Oncology (336 citations), Immunology (196 citations), Reproductive Medicine (54 citations), Molecular Biology (334 citations) and Cancer Research (66 citations). Carolynn E. Ohlson has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Jean J. Zhao, Thomas M. Roberts, Roderick T. Bronson, Hailing Cheng, Panagiotis A. Konstantinopoulos, Qiwei Wang, Elizabeth H. Stover, Joyce F. Liu, Brooke E. Howitt and Shaozhen Xie. Their work appears in journals such as Cell Reports, Proceedings of the National Academy of Sciences, Oncogene, Cancer Research and Digital WPI.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.